Bisphosphonates or denosumab discontinuation and risk of fractures: Response to the Letter by Anastasilakis et al.

Anagnostis Panagiotis<sup>*</sup>; Paschou Stavroula A; Mintziori Gesthimani; Ceausu Iuliana; Depypere Herman; Lambrinoudaki Irene; Mueck Alfred; Perez Lopez Faustino R; Rees Margaret; Senturk Levent M; Simoncini Tommaso; Stevenson John C; Stute Petra; Tremollieres Florence A; Goulis Dimitrios G

doi:10.1016/j.maturitas.2017.04.019

免费注册

赞收藏引用

科研之友

微信

新浪微博

Facebook

分享链接

Bisphosphonates or denosumab discontinuation and risk of fractures: Response to the Letter by Anastasilakis et al.

作者：Anagnostis Panagiotis^*; Paschou Stavroula A; Mintziori Gesthimani; Ceausu Iuliana; Depypere Herman; Lambrinoudaki Irene; Mueck Alfred; Perez Lopez Faustino R; Rees Margaret; Senturk Levent M; Simoncini Tommaso; Stevenson John C; Stute Petra; Tremollieres Florence A; Goulis Dimitrios G

来源：Maturitas, 2017, 102: 76-77.

DOI：10.1016/j.maturitas.2017.04.019